blood testing
The funding will be used to secure FDA clearance for its benchtop blood-testing system for use in doctor's offices, clinics and pharmacies.
The financing completes firm’s $60.1M Series B round.
CEO David Stein on how Babson Diagnostics is taking up Theranos' mission, but not its mantle.
The firm plans to further develop its blood typing technology.
The fate of the company's recently-announced research partnerships is unclear.
The Cedars Sinai-incubated company plans to launch its first product in Q2 2019.
Pixel by LabCorp's mail-away screens offer insights on heart health, diabetes, colorectal cancer and general wellness.
Housed on a biochip, the startup's technology can deliver results from a single drop of blood within 15 minutes.